Ossiam trimmed its position in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 19.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 53,131 shares of the company's stock after selling 12,513 shares during the quarter. Ossiam's holdings in Exelon were worth $2,000,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently added to or reduced their stakes in the company. Rosenberg Matthew Hamilton raised its stake in Exelon by 12.6% during the 4th quarter. Rosenberg Matthew Hamilton now owns 2,457 shares of the company's stock valued at $92,000 after purchasing an additional 275 shares during the last quarter. Wesbanco Bank Inc. raised its position in shares of Exelon by 3.1% during the fourth quarter. Wesbanco Bank Inc. now owns 9,951 shares of the company's stock valued at $375,000 after buying an additional 296 shares during the last quarter. PFG Investments LLC lifted its stake in shares of Exelon by 2.4% in the fourth quarter. PFG Investments LLC now owns 13,151 shares of the company's stock valued at $495,000 after buying an additional 305 shares during the period. Stratos Wealth Partners LTD. grew its position in Exelon by 1.7% during the fourth quarter. Stratos Wealth Partners LTD. now owns 18,505 shares of the company's stock worth $697,000 after buying an additional 311 shares in the last quarter. Finally, Blue Trust Inc. increased its stake in Exelon by 3.0% during the fourth quarter. Blue Trust Inc. now owns 11,085 shares of the company's stock valued at $450,000 after acquiring an additional 322 shares during the period. Institutional investors and hedge funds own 80.92% of the company's stock.
Insider Transactions at Exelon
In related news, EVP Colette D. Honorable sold 1,463 shares of the firm's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the completion of the transaction, the executive vice president now directly owns 2,271 shares of the company's stock, valued at approximately $92,134.47. This trade represents a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.10% of the company's stock.
Exelon Trading Down 0.2 %
EXC stock traded down $0.11 during midday trading on Friday, hitting $46.22. The company had a trading volume of 6,269,519 shares, compared to its average volume of 7,251,798. The company has a current ratio of 0.87, a quick ratio of 0.78 and a debt-to-equity ratio of 1.61. Exelon Co. has a 52 week low of $34.01 and a 52 week high of $48.11. The stock has a market cap of $46.66 billion, a price-to-earnings ratio of 18.87, a PEG ratio of 2.86 and a beta of 0.39. The stock's 50 day moving average price is $44.65 and its 200 day moving average price is $40.99.
Exelon (NASDAQ:EXC - Get Free Report) last released its earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same quarter last year, the business earned $0.60 earnings per share. As a group, equities research analysts expect that Exelon Co. will post 2.64 earnings per share for the current fiscal year.
Exelon Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a $0.40 dividend. The ex-dividend date was Monday, February 24th. This is a boost from Exelon's previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.46%. Exelon's dividend payout ratio is 65.31%.
Analysts Set New Price Targets
A number of equities analysts have commented on EXC shares. Guggenheim set a $47.00 price target on shares of Exelon and gave the company a "buy" rating in a research report on Tuesday. Morgan Stanley increased their price target on Exelon from $46.00 to $48.00 and gave the stock an "equal weight" rating in a research report on Thursday, March 20th. Scotiabank boosted their price objective on Exelon from $42.00 to $44.00 and gave the stock a "sector perform" rating in a research note on Thursday, February 13th. Barclays raised their target price on Exelon from $42.00 to $48.00 and gave the company an "overweight" rating in a research note on Tuesday, February 25th. Finally, BMO Capital Markets reissued an "outperform" rating on shares of Exelon in a report on Tuesday, February 4th. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $45.78.
Read Our Latest Research Report on Exelon
About Exelon
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Recommended Stories

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.